Published on
December 22, 2023
- 17:35 GMT
Rare Diseases: Considerations for the Development of Drugs and Biological Products
Docket Number: FDA-2015-D-2818 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for …
Distribution channels:
Healthcare & Pharmaceuticals Industry
